Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 16.35%127.030.0%$2227.08m
BIIBBiogen, Inc. 0.84%243.781.7%$657.15m
AMGNAmgen, Inc. 2.04%224.811.3%$567.96m
GILDGilead Sciences, Inc. 0.89%60.031.0%$514.37m
NVAXNovavax, Inc. 22.51%125.6992.9%$508.55m
BNTXBioNTech SE 4.79%109.990.0%$483.37m
VRTXVertex Pharmaceuticals, Inc. 3.95%226.711.9%$475.11m
REGNRegeneron Pharmaceuticals, Inc. 1.13%514.052.7%$473.60m
ILMNIllumina, Inc. 4.29%317.033.5%$393.59m
APVOAptevo Therapeutics, Inc. 1.32%44.3918.3%$233.60m
SGENSeagen Inc. 2.22%169.125.8%$182.62m
EXASEXACT Sciences Corp. 2.00%118.1919.6%$179.47m
ALXNAlexion Pharmaceuticals, Inc. 0.73%123.832.0%$157.60m
HALOHalozyme Therapeutics, Inc. -2.21%40.2318.4%$131.67m
SRNESorrento Therapeutics, Inc. 18.12%8.151.4%$127.58m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.